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Synaptic vesiclePhosphorylation and nitration of protein tyrosine residues are thought to play a role in signaling pathways at
the nerve terminal and to affect functional properties of proteins involved in the synaptic vesicle (SV)
exo-endocytotic cycle. We previously demonstrated that the tyrosine residues in the C-terminal domain of
the SV protein Synaptophysin (SYP) are targets of peroxynitrite (PN). Here, we have characterized the asso-
ciation between SYP and c-src tyrosine kinase demonstrating that phosphorylation of Tyr273 in the C-terminal
domain of SYP is crucial in mediating SYP binding to and activation of c-src. SYP forms a complex with
Dynamin I (DynI), a GTPase required for SV endocytosis, which may be regulated by tyrosine phosphoryla-
tion of SYP. We here report that, in rat brain synaptosomes treated with PN, the formation of SYP/DynI com-
plex was impaired. Noteworthy, we found that DynI was also modiﬁed by PN. DynI tyrosine phosphorylation
was down-regulated in a dose-dependent manner, while DynI tyrosine nitration increased. Using mass spec-
trometry analysis, we identiﬁed Tyr354 as one nitration site in DynI. In addition, we tested DynI self-assembly
and GTPase activity, which are enhanced by c-src-dependent tyrosine phosphorylation of DynI, and found
that both were inhibited by PN. Our results suggest that the site-speciﬁc tyrosine residue modiﬁcations
may modulate the association properties of SV proteins and serve as a regulator of DynI function via control
of self-assembly, thus inﬂuencing the physiology of the exo-endocytotic cycle.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Neurotransmitter release is triggered by Ca2+-dependent inﬂux at
the nerve terminal and relies on speciﬁc protein interactions between
synaptic vesicles (SVs)1and presynaptic terminals resulting in the fu-
sion process. After fusion, SV membrane proteins and lipids in turn
are recycled at the periactive zone that surrounds the release site to
restore functional SV pools [1]. To work appropriately, the synaptic
proteins associate transiently in functional complexes with mem-
brane promoting the correct steps from exo- to endocytosis.
Synaptophysin (SYP) is one of the most abundant integral proteins
of SV membrane [2] involved in several steps of synaptic function: +39 0649902040.
, michela.distasi@iss.it
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l rights reserved.including exocytosis, synapse formation, biogenesis, and endocytosis
of SVs [3–5]. SYP interacts with other synaptic proteins, including
Vesicle-Associated Membrane Protein 2 (VAMP2), also known as
Synaptobrevin 2 [6], the vesicular proton pump V-ATPase [7], the
adaptor protein AP1 [8] and Dynamin I (DynI) [5,9]. However, how
the multiple associations of SYP are regulated is still to be clariﬁed.
SYP shares with its homologous Synaptoporin and Pantophysin a
common transmembrane topology, with four membrane-spanning
domains and a short N- and a long C-terminal tail, both exposed on
the cytoplasmic side [10]. SYP C-terminal cytoplasmic tail contains
nine pentapeptide repeats, each starting with a tyrosine residue
(YG(P/Q)QC) that may be the target of tyrosine kinases within the
nerve terminal. Indeed, SYP is phosphorylated in vitro by the
non-receptor tyrosine kinase src [11], but the functional role of its
phosphorylation is still unknown [12]. It has been suggested that ty-
rosine phosphorylation of SYP may regulate its interaction with
DynI, a GTPase required for SV endocytosis, since the tyrosine-based
pentapeptide motifs are conﬁned to DynI binding sites [5,9]. Actually,
SYP forms a complex with DynI in vivo in a Ca2+-dependent manner
[9] and, recently, optical imaging and electrophysiological studies
have provided evidence that the C-terminal cytoplasmic tail of SYP
plays a role in facilitating rapid and efﬁcient SV endocytosis [13].
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nerve terminal and suggest that SYP/DynI complexes are involved in
exo-endocytosis (for a review on DynI see [14]).
We previously demonstrated that in rat brain synaptosomes treated
with peroxynitrite (PN), a potent oxidizing andnitrating species formed
in a diffusion-limited radical–radical reaction between nitric oxide and
superoxide anion [15], the tyrosine residues in the C-terminal cytoplas-
mic tail of SYP were either phosphorylated or nitrated [16]. The
formation of 3-nitrotyrosine (NO2Tyr) in proteins is an in vivo post-
translational modiﬁcation induced by nitric oxide-derived oxidants,
such as PN [17]. PN-mediated nitration is a selective process where
only a small amount of proteins is found nitrated and one or a few tyro-
sine residues are modiﬁed [17]. Because NO2Tyr are poor substrates for
tyrosine kinases, the nitration of a tyrosine residue may down-regulate
phosphotyrosine (pTyr)-dependent signaling [18–20]. On the other
hand, several in vitro studies have shown that PN may promote rather
than inhibit tyrosine phosphorylation [21–26]. In the nervous system,
protein tyrosine nitration is a major component of PN-dependent
cytotoxicity in the course of neurodegenerative disorders and structural
neuronal proteins have been found to be key targets for tyrosine
nitration. For instance, α-synuclein undergoes oligomerization upon
PN-dependent nitration, and oligomerized α-synuclein forms Lewis
bodies, the hallmark of Parkinson's disease [27]. In addition, the pres-
ence of amyloidβ nitrated at Tyr10 has been detected inAlzheimer's dis-
ease (AD) brain, as well as in brains from mouse models of AD [28].
Protein nitration may also contribute to amyotrophic lateral sclerosis
pathogenesis by interfering with the function of speciﬁc proteins, pro-
tein degradation pathways and phosphorylation cascade [29].
In a previous work, we showed that in rat brain synaptosomes
tyrosine-phosphorylated, but not tyrosine-nitrated SYP, binds to
c-src tyrosine kinase and enhances its catalytic activity. Moreover,
we identiﬁed by mass spectrometry analysis one nitration site at
Tyr250 and two phosphorylation sites at Tyr263 and Tyr273 in the SYP
C-terminal cytoplasmic tail [16]. To get additional insights into the
role of PN-dependent tyrosine modiﬁcations of SYP C-terminal cyto-
plasmic tail, we have further characterized the functional effects of
SYP tyrosine phosphorylation and nitration on c-src recruitment and
activity. Moreover, we have analyzed the formation of SYP/DynI com-
plex in synaptosomes treated with PN and we have identiﬁed a
site-speciﬁc nitration in DynI at Tyr354 by mass spectrometry analysis.
Since c-src-dependent tyrosine phosphorylation of DynI induces its
self-assembly and increases its GTPase activity, we have also inves-
tigated the effect of PN on both GTPase activity and self-assembly and
found that these functions were impaired. Collectively, our ﬁndings
advance our understanding of the critical role that PN-induced post-
translational modiﬁcations (phosphorylation and nitration) play at
the nerve terminal in modulating mutual afﬁnities of SYP with two
binding partners, DynI and c-src, both involved in the exo-endocytotic
cycle of SVs.
2. Materials and methods
2.1. Materials
Antibodies were obtained from the following sources: monoclonal
anti-phosphotyrosine (pTyr) (clone 4G10) and anti-3-nitrotyrosine
(NO2Tyr) (monoclonal and polyclonal) from Millipore Bioscience
Research Reagent (Billerica, MA, USA); anti-SYP (monoclonal and
polyclonal) and monoclonal anti-Syntaxin 1 from Synaptic System
(Göttingen, Germany); monoclonal anti-v-src (Ab-1, clone 327)
from Calbiochem (EDM Chemical, Merck, Darmstadt, Germany);
monoclonal anti-DynI from BD Biosciences (Franklin Lakes, NJ,
USA);monoclonal anti-lyn (clone sc-15) fromSanta Cruz Biotechnology
(Santa Cruz, CA, USA); peroxidase-conjugated goat anti-mouse and
goat anti-rabbit from Bio-Rad (Hercules, CA, USA). The antibody
against GST was in house-made [30]. Recombinant puriﬁed humansrc (pp60src) was purchased from Millipore Bioscience Research Re-
agent. Immunopure-Protein G and Protein A immobilized to Trysacryl
were purchased from Thermo Scientiﬁc (Rockford, IL, USA). Nitrocellu-
lose paper from Shleicher and Schuell Bioscience Inc. (Dassel, Germany).
[γ32P] ATP (>3000 Ci/mmol) was obtained from DuPont NEN (Boston,
MA, USA) and Chelex 100 from Bio-Rad. SYP C-terminal-derived
peptides containing tyrosine 250 (aa sequence 274–260), tyrosine 263
(aa sequence 261–271) and tyrosine 273 (aa sequence 272–288) were
synthesized by NeoMPS PolyPeptide Laboratories (Strasbourg, France).
CompleteTM protease inhibitor cocktail, EDTA-free, was obtained from
Roche Diagnostics (Basel, Switzerland). Commercial PN was purchased
from Alexis (Enzo Life Sciences Inc., Farmingdale, NY, USA). All other re-
agents were purchased from Sigma-Aldrich (St. Louis, MO, USA).
2.2. Methods
2.2.1. Synaptosomes preparation
Communities Council Directive (86/609/EEC) was formally guided
by the Italian Ministry of Health. Synaptosomes were prepared as de-
scribed by Carlin et al. [31] with minor modiﬁcations. Brieﬂy, brain
tissue was homogenized in 10 vol (w/v) of Buffer A (0.32 M sucrose,
0.5 mM EGTA, 4 mMHepes-NaOH, pH 7.4, 10 mMNaF, 1 mMNa3VO4
and CompleteTM) using a Teﬂon-glass grinder. The homogenate was
centrifuged at 1000 ×g for 5 min at 4 °C to remove nuclei and debris
and the supernatant centrifuged at 13,800 ×g for 10 min at 4 °C. The
resulting pellet was suspended in Buffer A, stratiﬁed on a discontinu-
ous sucrose gradient (0.85, 1 and 1.2 M v/v in Hepes buffered
sucrose) and centrifuged at 85,000 ×g for 2 h at 4 °C. The layer be-
tween 1.0 and 1.2 M sucrose (synaptosomal fraction) was collected
and centrifuged at 140,000 ×g for 20 min. Protein content was deter-
mined by Bicinchoninic Acid Assay (BCA kit, Thermo Scientiﬁc,
Waltham, MA, USA).
2.2.2. Peroxynitrite treatment
PNwas synthesized as described by Radi et al. [32]. The concentra-
tion of PN was determined by absorbance at 302 nm in 1.5 M NaOH
(ε302=1700 M−1 cm−1). Diluted stock solutions were freshly pre-
pared in 0.1 M NaOH. To avoid metal-catalyzed oxidation of PN, the
phosphate buffer was treated extensively with Chelex100 and all
samples contained 0.1 mM diethylenetriaminepenta-acetic acid. PN
was added as a single bolus directly to synaptosomes (1 mg/ml) in
150 mM phosphate buffer (pH 7.5). After 5 min at room temperature,
synaptosomes were washed once with phosphate buffer (pH 7.5).
Control experiments were performed with decomposed PN to ex-
clude the participation of contamination products. Decomposed PN
was obtained by adding PN to the phosphate buffer for 10 min at
room temperature before the addition to synaptosomes. Treatment
with 0.5 and 1 mM PN was performed in the presence of 25 mM
sodium bicarbonate (at pH 7.5, CO2 is 1.3 mM) to enable NO2Tyr
formation [33].
2.2.3. Immunoprecipitation and in vitro kinase assay
Immunoprecipitation and in vitro kinase assay were performed as
previously described [34]. Synaptosomeswere solubilized by incubation
for 30 min at 0 °C with an equal volume of 4× RIPA buffer (100 mM
Tris–HCl, pH 7.5, 0.6 M NaCl, 4% (w/v) Triton X-100, 4% (v/v)
Na-deoxycholate, 0.4% (v/v) SDS, 0.4 mM Na3VO4, 20 μg/ml leupeptin,
20 μg/ml aprotinin, and 4 mM PMSF), diluted twice with TBS (50 mM
Tris–HCl, pH 7.4, 150 mM NaCl) and then centrifuged at 12,000 ×g for
10 min at 4 °C. After preclearing with 20 μl of Protein A/G beads pre-
pared as a 50% (v/v) suspension for 1 h at 4 °C, supernatants were in-
cubated with the appropriate antibodies and the immunocomplexes
were precipitated by addition of Protein A or Protein G bead suspensions
(50% v/v). The immunoprecipitates were collected by centrifugation and
washed twice with RIPA buffer and twice with TBS. Bound proteins
were eluted with 4× SDS loading buffer, resolved on SDS-PAGE and
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assays, synaptosomes were solubilized in 20 mM Hepes, pH 7.4,
containing 140 mM KCl, 2 mM EDTA, 1% (v/v) Triton X-100, 0.1 mM
PMSF, 0.1 mM Na3VO4 and CompleteTM and incubated overnight with
anti-SYP and anti-DynI antibodies. The kinase assay was performed by
incubating the puriﬁed human pp60src (0.5 U) with recombinant
proteins or peptides in kinase buffer (20 mM Tris–HCl, pH 7.4,
10 mM MnCl2, 0.1 mM Na3VO4) containing 1–2 μCi [γ32P] ATP
(>3000 Ci/mmol) for 10 min at room temperature. When indicated,
an exogenous substrate, such as enolase, was added to the reaction
mixture. The kinase reaction was stopped by adding 4× SDS loading
buffer and the samples were subjected to SDS-PAGE. The dried gels
were exposed to X-ray ﬁlm for autoradiography.
2.2.4. Gel electrophoresis and Western Blot analysis
Proteins were separated on 10% SDS-PAGE or using precast 4–12%
NuPAGE-Gels (Novex, precast gels from Invitrogen Life Science, Paisley,
UK) and transferred to nitrocellulose paper. Blots were washed with
TTBS (TBS containing 0.05% Tween-20) and blocked with 3% bovine
serum albumin (w/v)-TTBS for 2 h. Washed nitrocellulose ﬁlters
were incubated overnight at 4 °C with the appropriate antibodies.
After extensive washes in TTBS, the immunoreactive bands were
detected by chemiluminescence coupled to peroxidase activity
according to the manufacturer's speciﬁcations (ECL kit, Thermo
Scientiﬁc, Waltham, MA, USA). The speciﬁcity of the polyclonal and
monoclonal anti-NO2Tyr antibodies was established by competition
experiments by a pre-incubation of the antibody with 5 mM
NO2Tyr for 10 min, which switched off the ECL signals obtained
with both monoclonal and polyclonal antibodies.
2.2.5. Recombinant protein expression and puriﬁcation
DNA coding for the C-terminal cytoplasmic region of SYP
(aa 219–308) was ampliﬁed by RT-PCR of total RNA from mouse
brain and subcloned into pCRIITOPO (Invitrogen Life Science, Paisley,
UK). After EcoRI-restriction, SYP insert was subcloned into pGEX-4T-1
(GE healthcare Bio-Sciences Corp., Piscataway, NJ, USA) and the
construct pGEX-SYP 219–308 was used to transform BL21 and TKB1
E. coli cells. To express glutathione S-transferase (GST)-fused recombi-
nant protein, cells were incubated for 1 h at 37 °C in the presence
of 0.5 mM isopropyl-β-D-thiogalactoside. Tyrosine-phosphorylated
GST-SYP (GST-SYPpY) was expressed in TKB1 E. coli cells (Agilent
Technologies, Santa Clara, CA, USA), a strain that allows obtaining
tyrosine-phosphorylated recombinant proteins. GST-Grb2-SH3 do-
main was expressed in E. coli BL21 strain [35]. GST-fusion proteins
were puriﬁed by afﬁnity chromatography on glutathione-Sepharose
beads (GE healthcare Bio-Sciences Corp., Piscataway, NJ, USA) following
the manufacturer's instructions. Nitrated GST-SYP (GST-SYPNY) was
prepared by treatment of GST-SYP with 1 mM PN, as described above,
to obtain a site-speciﬁc nitration on Tyr250 previously identiﬁed by
mass spectrometry analysis [16].
2.2.6. Pull-down experiments
GST-SYP, GST-SYPpY and GST-SYPNY conjugated with glutathione-
Sepharose beads were used in binding assays of synaptosome extracts
obtained by solubilization in binding buffer (20 mM Hepes, pH 7.4,
150 mM NaCl, 1% (v/v) Triton X-100, 0.1 mM PMSF and CompleteTM)
for 1 h at 0 °C. After centrifugation at 15,000 ×g for 10 min, synapto-
somal extracts (7.5 mg/ml) were incubated with GST fusion proteins
(20 μl of beads suspension) overnight at 4 °C under gentle rotation.
After binding, the beads were washed three times with 1 ml of bind-
ing buffer and boiled in 4× loading buffer, and eluted bound proteins
resolved on SDS-PAGE and transferred to nitrocellulose. Sepharose-
immobilized GST-Grb2-SH3 domain was used in pull-down experi-
ments of untreated and PN-treated synaptosomes to purify endoge-
nous DynI [36]. Five μl of Sepharose beads (25% suspension) was
added to synaptosomal extracts (5 mg/ml) obtained after solubilizationfor 30 min at 0 °C in binding buffer and centrifugation at 10,000 ×g for
10 min. Then, the beads were washed seven times with binding buffer,
solubilized in 4× loading buffer and subjected to SDS-PAGE and WB
analysis. Biotynilated-peptides (2 mg/ml) used in pull-down assay
were previously linked to Tetralink Tetrameric Avidin resin overnight
at 4 °C.
2.2.7. In vitro DynI GTPase activity and self-assembly assay
DynI was immunoprecipitated, as described above, with speciﬁc an-
tibodies from solubilized synaptosomes and the GTPase activity was
measured in the immunocomplexes following the procedure described
in the GTPase Assay System (Innova Biosciences, Cambridge, UK). DynI
self-assembly was monitored by a sedimentation assay [37]. Endoge-
nous DynI was puriﬁed from synaptosomes by GST-Grb2-SH3 as de-
scribed above and eluted from beads in 20 mM PIPES, pH 6.8 and 2 M
NaCl. After elution, the protein was dialyzed into high-ionic strength
buffer (20 mM Hepes, pH 7.4, 150 mM NaCl, 2 mM EGTA, 2 mM
MgCl2, 0.1 mM PMSF) for 2 h with three buffer changes, followed by
concentration in Microcon, cut-off 30 kDa (Millipore Bioscience
Research Reagent, Billerica,MA,USA). Subsequently, the proteinwas di-
luted 10-fold into either high-ionic strength buffer or low-ionic
strength buffer (20 mM PIPES, pH 7.4, 20 mM Hepes, 2 mM EGTA,
2 mM MgCl2, 0.1 mM PMSF) on ice. Supernatant and pellet fractions
were obtained after centrifugation at 150,000 rpm for 20 min in a
TL100 (Beckman Instruments Inc., Fullerton, CA, USA). The pellet frac-
tionswere dissolved in 4× loading buffer,while DynI in the supernatant
fractionswas precipitatedwith TCA 20% (v/v). DynI in each fractionwas
resolved on 4–12% NuPAGE-Gels and revealed on gel by silver staining
or on nitrocellulose by WB with anti-DynI antibody.
2.2.8. Identiﬁcation of nitrated tyrosine residues in DynI protein by
mass spectrometry
DynI obtained in the pull-down experiment with GST-Gbr2-SH3
from 0.5 mM PN-treated synaptosomes, after separation on 4–12%
NuPAGE-Gels, was stained with Coomassie Colloidal Blue (Invitrogen
Life Science, Paisley, UK). The detectable bands were cut away from
the gel, cut again in small pieces, washed with water and destained
with a solution containing 50 mM ammonium bicarbonate/acetoni-
trile (1:1 v/v) (CH3CN, Merck, Darmstadt, Germany). The protein
bands were subsequently treated to reduce and alkylate cysteine res-
idues with DTT and iodoacetamide, respectively, and ﬁnally digested
with 12.5 ng/ml trypsin (sequencing grade modiﬁed porcine trypsin,
Promega, Madison, WI, USA) in 25 mM ammonium bicarbonate at
37 °C as elsewhere described [38]. Peptide mixtures were analyzed by
nanoﬂow reversed-phase liquid chromatography tandem mass spec-
trometry (RP-LC–MS/MS) using an HPLC Ultimate 3000 (DIONEX,
Sunnyvale, CA, USA) connected on line with a linear Ion Trap (LTQ,
ThermoElectron, San Jose, CA, USA). Peptides were desalted on a trap
column (Acclaim PepMap 100 C18, LC Packings, DIONEX) and then sep-
arated in a reverse phase column – a 10 cm long fused silica capillary
(Silica Tips FS 360-75-8, New Objective, Woburn, MA, USA) –
slurry-packed in-house with 5 μm, 200 Å pore size C18 resin (Michrom
BioResources, Auburn, CA, USA). Peptides were eluted with a linear
gradient from 96% A (H2O with 5% acetonitrile (ACN) and 0.1% formic
acid) to 60% B (ACN with 5% H2O and 0.1% formic acid) in 40 min, at
300 nl/min ﬂow rate. Analyses were performed in positive ion mode
and the HV Potential was set up around 1.7–1.8 kV. Full MS spectra
ranging from m/z 400 to 2000 Da were acquired in a data-dependent
mode: each full MS scan was followed by ﬁve MS/MS scans, where
the ﬁve most abundant molecular ions were dynamically fragmented
by collision-induced dissociation, using a normalized collision energy
of 35%. Target ions already fragmented were dynamically excluded for
30 s. Tandem mass spectra were matched against SwissProt database
containing rat proteins and through SEQUEST algorithm [39] incorpo-
rated in Bioworks software (version 3.3, Thermo Electron) using fully
tryptic cleavage constraints with one miss cleavage permitted, static
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nine (+16 Da) or nitrated tyrosine (+45 Da) as variable modiﬁcation.
Precursor and fragment ions tolerance were 1.5 Da and 1 Da. A peptide
has been considered legitimately identiﬁed when it achieved cross cor-
relation scores of 1.8 for [M+H]1+, 2.5 for [M+2 H]2+, 3 for
[M+3 H]3+, and a peptide probability cut-off for randomized identiﬁ-
cation of pb0.001.
3. Results
3.1. Phosphotyrosine 273 (pTyr273) in SYP C-terminal domain is involved
in the binding to and activation of c-src
Wehave previously demonstrated [16] that, following PN treatment,
SYP can be both phosphorylated and nitrated in a dose-dependentman-
ner. We also found that tyrosine-phosphorylated, but not tyrosine-
nitrated, SYP bound to the c-src tyrosine kinase andenhanced its catalyt-
ic activity. Mass spectrometry analysis of the SYP C-terminal domain (aa
219–308), expressed as GST-fused recombinant protein, showed in
GST-SYPpY the presence of two phosphorylated tyrosine residues in
the amino acids sequence 261–271 and 272–288, respectively. In
GST-SYPNY only one nitrated tyrosine was mapped in the amino acid
sequence 247–260 [16]. MS/MS analysis allowed assigning the phos-
phorylation sites to Tyr263 and Tyr273, and the nitration site to Tyr250
[16] (see peptide sequences in Fig. 1A and B). To further characterize
the functional consequences of SYP tyrosine phosphorylation and nitra-
tion on c-src recruitment and activity, we performed pull-down and
in vitro kinase assays using peptides corresponding to the identiﬁed
sequences, containing Tyr263 (peptide 263) or Tyr273 (peptide 273),
phosphorylated and non-phosphorylated, or Tyr250 (peptide 250)
nitrated and non-nitrated. Each peptide was conjugated to biotin atPeptide 263: Biotinyl-Gly-Asp261-Ser-(p)Tyr263-Gly-Pro-
Peptide 273: Biotinyl-Gly-Asp272-(p)Tyr273-Gly-Gln-Pro-
GST-SY
kDa 
KETGWAAPFMRAPPGAPEKQPAPGDAYGDAGYGQGPGGYGPQDSYGPQ
219 
D261S(pY263)G
D247AG(NY250)GQGPGGYGPQ260
Peptide 250: Biotinyl-Gly-Asp247-Ala-Gly-(N)Tyr250-Gly-
98 
62 
28 
38 
49 
A 
C
B
WB c-src  WB c-src  
Fig. 1. SYP peptide containing phosphorylated Tyr273 binds to c-src and lyn. (A) Amino acid seq
Boxes indicate the peptide sequences containing the nitrotyrosine residue (NTyr250) and the tw
acid sequence of the peptides conjugated with biotin at the N-terminus used in the experimen
containing Tyr250/NTyr250, Tyr263/pTyr263 or Tyr273/pTyr273 linked to avidin-Tetralink beads and
of c-src and lyn in the pulled-down proteins was revealed byWB analysis with anti-c-src and a
nescence coupled to peroxidase activity (ECL). The molecular mass standards in kDa are indicathe N-terminus to allow the binding to Tetralink-avidin beads. The con-
jugated peptides were used to pull-down c-src from rat brain synapto-
somal extracts. As shown in Fig. 1C (left panel), WB analysis with an
anti-c-src antibody revealed that the phospho-peptide containing
pTyr273 is able to precipitate c-src more efﬁciently, compared to
the phospho-peptide containing pTyr263. Notably, the nitro-peptide
NTyr250, as well as the non-modiﬁed analogous peptides (Tyr263,
Tyr273, Tyr250), did not bind to c-src. As expected, the pull-down with
Sepharose-immobilized GST-SYP, GST-SYPpY andGST-SYPNY of synapto-
somal extracts showed that GST-SYPpYwas able to bind to c-srcmore ef-
ﬁciently, compared to GST-SYP and GST-SYPNY (Fig. 1C, central panel).
Interestingly, GST-SYPpY and phospho-peptide 273 also bind to lyn
(Fig. 1C, right panel), another tyrosine kinase of the src family expressed
in the nervous system, suggesting a common recognition mechanism
between SYP and this class of kinases.
Since tyrosine-phosphorylated SYP enhances c-src kinase activity
[16], we investigated which tyrosine residue in SYP C-terminal do-
main was responsible for the stimulation of the enzymatic activity
in puriﬁed pp60src. In vitro kinase assay was carried out in the pres-
ence of increasing concentrations (0.1–1 mM) of phosphorylated or
non-phosphorylated peptides 273 and 263. The activity of pp60src
was measured as autophosphorylation and phosphorylation of the
exogenous substrate enolase (Fig. 2A). Both enolase phosphorylation
and autophosphorylation of pp60src were found and signiﬁcantly in-
creased in a dose-dependent manner in samples containing the pep-
tide pTyr273 compared to the analogous non-phosphorylated peptide
(Fig. 2A, upper panel). The peptide 263, either phosphorylated or
non-phosphorylated, did not affect pp60src activity (Fig. 2A, lower
panel). In the same experimental conditions, the nitro-peptide 250
failed to activate pp60src (data not shown). Again, activation of
pp60src was also observed with GST-SYPpY but not with GST-SYPNY orc-src 
Gln-Gly-Gly-Tyr-Gln-Pro271 
Ala-Ser-Gly-Gly-Gly-Gly-Gly-Tyr-Gly-Pro-Gln-Gly288 
P
GGYQPDYGQPASGGGGGYGPQGDYGQQGYGQQGAPTSFSNQM 
308 
PQGGYQP271
D272(pY273)GQPASGGGGGYGPQG288!
Gln-Gly-Gly-Gly-Tyr-Gly-Pro-Gln260 
lyn 
WB lyn  
GST-SYP
uence of SYP C-terminal domain (219–308) expressed as protein fused to GST (GST–SYP).
o phosphotyrosine residues (pTyr263 and pTyr273), identiﬁed as targets of PN. (B) Amino
ts described below. (C) Pull-down assay of rat brain synaptosomal extract with peptides
with GST–SYP, GST–SYPpY and GST–SYPNY immobilized to Sepharose beads. The presence
nti-lyn antibodies, respectively. The immunoreactive bands were detected by chemilumi-
ted on the left. The results shown are representative of three independent experiments.
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over, the two tyrosine-phosphorylated residues (273 and 263) did not
show additive effect, since in the sample containing both pTyr273 and
pTyr263 (0.5 mM each) the autophosphorylation of pp60src was similar
to that measured in the sample containing pTyr273 (0.5 mM) only
(Fig. 2B).
3.2. Peroxynitrite-dependent tyrosine modiﬁcations of SYP inhibit its
binding to DynI
Although the functional role of SYP tyrosine phosphorylation as
well as tyrosine nitration is still unknown, it is tempting to speculate
that tyrosine phosphorylation of SYP may regulate the associations
with its binding partners. In particular, it has been proposed to have
a role in the interaction of SYP with DynI, since the tyrosine-based
pentapeptide motifs in SYP C-terminal region contain DynI binding
sites [9]. To test if PN-dependent modiﬁcations in SYP C-terminal
tyrosine residues may modulate the interaction between SYP and
DynI, two different approaches were conceived: pull-down assays
from solubilized synaptosomes using Sepharose-immobilized GST-SYP
and immunoprecipitation of SYP from untreated and PN-treated synap-
tosomes solubilized under conditions that preserve protein–protein
interactions. The presence of DynI in the immunocomplexes was re-
vealed by WB analysis using speciﬁc anti-DynI antibody. We found
that the C-terminal tail of SYP (GST-SYP) very efﬁciently bound to and
precipitated DynI. Noteworthy, GST-SYPpY and GST-SYPNY pulled-enolase 
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Fig. 2. SYP peptide containing phosphorylated Tyr273 activates pp60src. (A) Autoradio-
graphs of in vitro kinase assay of recombinant puriﬁed pp60src (0.5 U) performed in the
presence of peptides containing Tyr273 and Tyr263 (upper and lower panels, respectively),
phosphorylated (pTyr) and non-phosphorylated (Tyr), at concentrations of 0.1, 0.5
and 1 mM. Enolase (1 μg) was added to the reaction mixture as exogenous substrate.
(B) Autoradiograph of in vitro kinase assay of pp60src (0.5 U) performed in the presence
of peptides pTyr263, pTyr273 (0.5 mM) or a mixture of pTyr263/pTyr273 at a concentration
of 0.5 mM each, and in the presence of GST–SYP, GST–SYPpY and GST–SYPNY. The kinase
assays were carried out in the presence of 1–2 μCi [γ32P] ATP. [32P]-labeled proteins
were resolved on 10% SDS-PAGE and shown on dried gel by exposure to X-ray ﬁlm. The
results shown are representative of four independent experiments.down DynI to a lesser extent than GST-SYP (~30% and ~50%, respec-
tively, Fig. 3A, upper panel). Conversely, we attempted to pull-down
DynI from solubilized synaptosomes using peptides (263, 273 and
250) immobilized on Tetralink-avidin beads, but we did not reveal
the presence of DynI in any of the conditions tested (results not
shown). The co-immunoprecipitation experiments using an anti-
SYP antibody showed that the formation of SYP/DynI complex was
impaired by modiﬁcations induced by PN (Co-IP SYP in Fig. 3B). Sim-
ilarly, the co-immunoprecipitation with anti-DynI revealed that less
SYP was associated to DynI in synaptosomal samples treated with PN
(Co-IP DynI in Fig. 3B). As expected, neither anti-SYP nor anti-DynI
immunocomplexes contained Syntaxin 1 (Fig. 3B) [9]. DynI typically
migrates as one band in the SDS-PAGE, but in the Co-IP experiments,
as in that described hereafter, WB analysis revealed a doublet
(Fig. 3B, Input column, central panel), probably due to an alternative
splicing of DynI, as described by Chan et al. [40].
3.3. Peroxynitrite down-regulates tyrosine phosphorylation of DynI
Some components of the vesicular endocytic machinery have been
shown to undergo regulated tyrosine phosphorylation mediated by
the tyrosine kinase c-src. SYP is one of the major substrates of
vesicle-associated c-src. Another target of c-src is DynI, which can
directly interact with src-SH3 domain [41]. We investigated the tyro-
sine phosphorylation status of DynI following PN treatment of synap-
tosomes. DynI was immunoprecipitated with a speciﬁc antibody and
tyrosine phosphorylation was revealed by WB analysis with an
anti-pTyr antibody. As shown in Fig. 4(A), PN down-regulated DynI
phosphorylation in a dose-dependent manner. Inhibition of DynI
phosphorylation was also evident in synaptosomes treated with com-
mercial PN (Alexis) at 0.3 mM concentration (Fig. 4A). As a control,
the nitrocellulose was probed with an anti-DynI antibody to assess
that equal amounts of DynI were immunoprecipitated in the different
experimental conditions (Fig. 4A). We also performed an in vitro
phosphorylation assay in the presence of [γ32P] ATP by adding
puriﬁed pp60src (0.5 U) to DynI-immunocomplex obtained from
untreated and PN-treated synaptosomes. We found that the incorpo-
ration of [32P] into DynI decreased dose-dependently after PN treat-
ment (Fig. 4B). This experiment substantiates the results shown in
Fig. 4(A), underlying PN-induced down-regulation of the DynI phos-
phorylation signal. Since DynI can directly interact with src-SH3
domain, we quantiﬁed both the amount and the enzymatic activity of
c-src associated with DynI in co-immunoprecipitation assays from
untreated and PN-treated synaptosomes. We found that PN dose-
dependently inhibited both the interaction between DynI and c-src, as
revealed by WB analysis with anti-c-src antibody (Fig. 4C), and the
activity of c-srcmeasured in the in vitro kinase assay as autophosphoryl-
ation and phosphorylation of enolase (Fig. 4D). The high molecular
weight bands on the autoradiograph (Fig. 4D) corresponded to
immunoprecipitated DynI, whose phosphorylation signal was reduced
by PN treatment, as shown in Fig. 4B.
3.4. Identiﬁcation of tyrosine 354 in DynI protein as target of peroxynitrite
One of the oxidative reactions induced by PN is the modiﬁcation of
tyrosine residues in proteins to yield NO2Tyr, and it has been suggested
that this modiﬁcation impairs phosphotyrosine signaling. To investigate
whether PN-dependent down-regulation of DynI tyrosine phosphoryla-
tion may be caused by NO2Tyr formation, we immunoprecipitated DynI
from PN-treated synaptosomes and subjected the immunocomplex to
WB analysis using anti-NO2Tyr antibodies. Unfortunately, the analysis
failed to reveal any signal corresponding to the molecular weight of
DynI (data not shown). To enrich for the protein, DynI was afﬁnity
puriﬁed from synaptosomal extract using recombinant SH3 domain, a
technique that allows the isolation of high amounts of biologically active
native DynI rapidly and reproducibly [36]. As afﬁnity ligand, we used
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Fig. 3. PN-dependent modiﬁcations of SYP inhibit its binding to DynI. (A) Pull-down assay with Sepharose-immobilized GST–SYP, GST–SYPpY and GST–SYPNY from rat brain syn-
aptosomal extract. The presence of bound DynI in pulled-down samples was revealed by WB analysis with anti-DynI antibody (upper panel). Input, starting material of synapto-
somal extract. The pulled-down proteins were also probed with anti-SYP and anti-GST antibodies (central and lower panels, respectively), as control. (B) Co-immunoprecipitation
(Co-IP) assays with anti-SYP and anti-DynI antibodies from untreated or 0.1–1 mM treated synaptosomes. After Co-IP, the presence of DynI and SYP was revealed using the respec-
tive speciﬁc antibodies. The nitrocelluloses were probed with anti-Syntaxin 1 as control. Input, starting material of synaptosomal extract. The results shown are representative of
three independent experiments.
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Prolin-Rich Domain (PRD). GST-Grb2-SH3 pulled-down a protein of
about 100 kDa, revealed on gel by Coomassie Colloidal Blue staining
(Fig. 5A) and identiﬁed as DynI by WB analysis with the anti-DynI anti-
body (Fig. 5B, left panel). Noteworthy, the same blot probed with an
anti-NO2Tyr antibody showed a strong NO2Tyr signal associated with
DynI band in the pull-down obtained from synaptosomes treated with
1 mM PN (Fig. 5B, right panel). To map the DynI tyrosine residues mod-
iﬁed by PN, the native DynI, pulled-downwith GST-Grb2-SH3 from syn-
aptosomes treated with 0.5 mM PN, was separated on a 4–12% NuPAGE
gel, the appropriate band was digested with trypsin and the peptide
mixture analyzed by Liquid Chromatography tandem Mass Spectrome-
try (LC–MS/MS). The MS/MS analysis identiﬁed a nitrated Tyr354 located
in the tryptic peptide containing amino acids 344–361 (Fig. 6). Not all
the DynI molecules carried this modiﬁcation as indicated by the
presence of MS/MS spectrum of the same peptide without any mod-
iﬁcation. The extent of Tyr354 nitration was tricky to evaluate,
although from the extract ion analysis, it appears to be less than 5%
(supplementary Figure). In addition, LC–MS/MS analysis revealed
that in untreated synaptosomes DynI showed a basal level of nitra-
tion. Indeed, we identiﬁed also nitrated Tyr125, Tyr541 and Tyr669,
however, more interestingly, nitrated Tyr354 was detected only
after PN treatment of synaptosomes.3.5. Peroxynitrite inhibits GTPase activity and self-assembly of DynI
It is known that phosphorylation of DynI by c-src induces its self-
assembly and increases its GTPase activity [42]. Upon recruitment via
the C-terminal PRD, DynI oligomerizes into helical structures around
the neck of budding vesicles and catalyzes vesicle scission in a
GTP-hydrolysis-dependent manner. Based on the results described
above, we investigated whether PN-dependent tyrosine modiﬁca-
tions affected DynI GTPase activity. We measured the GTPase activity
in the DynI immunocomplex obtained from PN-treated synapto-
somes. The results clearly demonstrated that PN signiﬁcantly down-
regulated the DynI GTPase activity in a dose-dependent manner
(Fig. 7). Commercial PN (Alexis) at 300 μM induced a decrease of DynI
GTPase activity comparable to that measured in the 0.1 mM PN-treated
sample (Fig. 7). Treatment of synaptosomes with decomposed PN did
not affect DynI GTPase activity (Fig. 7).
Isolated DynI self-assembles in vitro in low-salt buffers into
ordered formations of rings and helical arrays [37], similar morpho-
logically to helical structures assembled at the necks of budding ves-
icles [43]. High-ionic strength conditions, conversely, do not permit
DynI self-assembly. Because self-assembly of DynI is known to regu-
late its GTP hydrolysis rate [44], we hypothesized that the observed
decrease in GTPase activity of DynI might depend on its diminished
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Fig. 4. PN down-regulates tyrosine phosphorylation of DynI. (A) WB analysis of DynI immunoprecipitated from synaptosomes (IP DynI), untreated or treated with 0.1 or 1 mM PN
or with commercial 0.3 mM PN (Alexis), with anti-pTyr and anti-DynI antibodies. Input, starting material extract of synaptosomes treated with 0.1 mM PN. Equivalent DynI
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the reaction was carried out in the presence of 1–2 μCi [γ32P] ATP. [32P]-labeled proteins were resolved on 10% SDS-PAGE and revealed on dried gel by exposure to radiographic
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[32P] into the proteins revealed on dried gel by exposure to radiographic ﬁlm.
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and 0.5 mM PN-treated synaptosomes using Sepharose-immobilized
GST-Grb2-SH3 and eluted from beads in 2 M NaCl. WB analysis with
anti-DynI of GST-Grb2-SH3-bound DynI was performed before and
after elution to verify that the same amount of protein was recovered
and subjected to self-assembly assay (Fig. 8A). After dilution into
low-ionic or high-ionic strength buffers, DynI was collected by
sedimentation at high-speed centrifugation. DynI in each fraction
was revealed on gel by silver staining (Fig. 8B, upper panel) or on
nitrocellulose with the anti-DynI antibody (Fig. 8B, lower panel).
Interestingly, DynI coming from the PN-treated sample lost the ability
to self-assembly, since at low salt it remained in its disassembled
status in the supernatant compared to control sample. As expected,
in high salt, DynI was present mainly in the supernatant in all samples
tested (Fig. 8B).
4. Discussion
This study provides evidence of the role played by PN-induced pro-
tein tyrosine nitration and phosphorylation in modulating functional
properties and association of proteins involved in exo-endocytosis ofSVs, a process tightly linked to neurotransmitter release and synaptic
transmission. Besides SV protein SYP [16], we found that DynI, a GTPase
required for SV endocytosis, is also modiﬁed by PN. We observed that
the oxidative changes induced by PN at the nerve terminal modulate
the interactions of SYP with c-src and DynI, and affect DynI GTPase
activity and self-assembly.We show for theﬁrst time that the functional
properties of DynI are down-regulated in response to increasing con-
centration of PN, suggesting a new level of regulation of endocytotic
machinery.
The reactive oxygen and nitrogen species can be critical for excitato-
ry synaptic activity and, aswe previously described, PN can signiﬁcantly
stimulate vesicle exocytosis and induce endogenous glutamate release
from synaptosomes [45]. SVs fuse with the membrane of the nerve ter-
minal during neurotransmitter release and are subsequently retrieved
and recycled. This process relies on speciﬁc protein interactions to
form transient functional complexes promoting the correct steps from
exo- to endocytosis.
SYP is known to interact with other proteins of the SV membrane
as VAMP2 [6] and the 38 kDa subunit of the vacuolar V-ATPase [7] to
regulate exocytotic vesicle fusion at the level of SNARE complex or
fusion pore formation [3]. Moreover, SYP is the major tyrosine
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the non-receptor tyrosine kinase c-src in vitro [11]. We previously
showed that in rat brain synaptosomes treated with PN, depending
on its concentrations, SYP can be tyrosine phosphorylated at Tyr263
and Tyr273 and tyrosine nitrated at Tyr250. When phosphorylated,
but not nitrated, SYP binds to c-src-SH2 domain and enhances c-src
kinase activity [16]. In this study we have further characterized the
association between SYP and c-src demonstrating that the peptide
containing phosphotyrosine Tyr273, but not phosphotyrosine Tyr263
or nitrotyrosine Tyr250, speciﬁcally binds to and activates c-src. In ad-
dition, phosphotyrosine Tyr273 also recruits lyn, another kinase of the
src family expressed in the nervous system, suggesting a common
recognition mechanism between SYP and this class of kinases. It has
been reported that c-src activity and c-src/SYP association are in-
creased in the hippocampus of rats trained in a spatial memory task
[46] and that tyrosine phosphorylation of SYP is enhanced upon
synaptic stimulation, as it is known to occur during the long-term
potentiation [47]. Since, in our experimental model, nitrated-SYP does
not bind to nor activates c-src, we hypothesize that signaling processes
relying on tyrosine phosphorylation may be potentially down-
regulated. In vivo, site-speciﬁc nitration may serve as a pathogenic
mechanism for inactivating catalytic proteins and promoting altered as-
sembly of structural proteins in neurodegenerative diseases [48].
The C-terminal domain of SYP is also involved in the interactionwith
DynI. Indeed, a progressive removal of the nine YG(P/Q)QC repeats in
SYP C-terminal results in a successive loss of DynI binding [9] and in re-
duction of endocytosis during neuronal activity [49]. Given the
well-established role of DynI in endocytosis [14], SYP/DynI complex
might take part in vesicle recycling by targeting DynI to SV membrane
[49]. It has been suggested that SYP tyrosine phosphorylation may
limit the pool of DynI competent to associate with SYP [9]. It isreasonable to hypothesize that tyrosine phosphorylation and/or nitra-
tion of SYP inﬂuences its interaction with DynI. In fact, we found
that the association between SYP and DynI in rat brain synaptosomes
was impaired by increasing concentrations of PN. Moreover, the for-
mation of SYP/DynI complex was mediated by the full length
C-terminal domain of SYP, in agreement with previous ﬁndings [9],
since none of the peptides (250, 263 and 273) used in pull-down assays
was able to precipitate DynI. The observation that SYP/DynI complex in
brain extracts is promoted by dissociation of VAMP2 from SYP and by
Ca2+ inﬂux suggests that DynI only associates with SYP after the disas-
sembly of SYP/VAMP2 complex [9]. It has been observed that, in rats in-
fusedwith amyloidβ1–40, SYP is both nitrated and phosphorylated and
changes its ability to recruit VAMP2 [50]. Actually, we found that SYP
associated with higher amounts of VAMP2 in synaptosomes treated
with PN (C. Mallozzi, C. D'Amore and A.M.M. Di Stasi, unpublished ob-
servations), thus blocking the binding of DynI with SYP and affecting
the correct targeting of DynI to the SV membrane.
At the nerve terminal, DynI is one of the substrates of c-src and
directly interacts with c-src-SH3 through its PRD [41]. This association
suggests a role for src inmembrane trafﬁc events [51]. The c-src-mediated
tyrosine phosphorylation of DynI is required for agonist-induced endocy-
tosis of β2-adrenergic [52] and M1 muscarinic acetylcholine [53] recep-
tors, but the mechanisms whereby phosphorylation of DynI regulates
SV endocytosis are still unclear. Here, we found that, in a dose-
dependent manner, PN inhibits the interaction between DynI and
c-src and down-regulates tyrosine phosphorylation of DynI.We also ob-
served that DynI isolated from PN-treated synaptosomes is no longer
recognized as a substrate by the exogenous tyrosine kinase pp60src. In
our experimental conditions, the kinase activity of DynI-associated
c-src was not increased by PN. Onofri et al. [51] reported that another
synaptic protein containing PRD, Synapsin I, recruits c-src through its
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turn phosphorylates Synapsin I. Phosphorylated Synapsin I recognizes
c-src-SH2, allowing further activation of c-src. We cannot exclude that
DynI PRD interacts with c-src-SH3, but it is conceivable that DynI,
after PN treatment, does not recruit c-src-SH2 and does not enhance
c-src kinase activity.
Remarkably, we have identiﬁed by LC–MS/MS analysis one major
nitration site at Tyr354 in DynI isolated from synaptosomes treated
with PN. LC–MS/MS analysis revealed also that in untreated synapto-
somes DynI showed a basal level of nitration on Tyr125, Tyr541 andTyr669, however these sites of nitration were not modiﬁed by PN
and did not affect DynI functional properties. Tyr354 was instead
nitrated only after PN treatment of synaptosomes implying that this
site-speciﬁc post-translational modiﬁcation likely accounts for DynI
dysfunction. It is interesting to note that Tyr354 has been previously
identiﬁed as phosphorylated in vitro by c-src [42], while in vivo anal-
ysis showed that Tyr597, but not Tyr354, is phosphorylated in response
to EGF stimulation in COS-7 cells [42]. Three tyrosine phosphorylation
sites, at position 80, 125 and 354, have been identiﬁed in mouse
brain DynI using large scale phosphoproteomic screens for tyrosine
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tional role of DynI tyrosine phosphorylation in controlling SV endocy-
tosis remain open questions.
The presence of a nitro-group on a phosphorylable tyrosine residue
may account for the impairment of phosphotyrosine signaling of DynI
mediated by PN. Emerging data support a strong link between NO2Tyr
formation and both activation and interference with phosphotyrosine-
dependent signaling pathways in a variety of cellular responses
[17,18,55]. In this study we point out for the ﬁrst time that DynI is the
target of PN, which induces nitration of a speciﬁc tyrosine residue. The
formation of NO2Tyr in DynI well correlates with and may account for
the failure of tyrosine phosphorylation due to PN treatment.
DynI is a mechanochemical GTPase that oligomerizes around the
neck of clathrin-coated pits and catalyzes the “pinching off” of
endocytosing vesicles in a GTP-hydrolysis-dependent manner. The
molecular details of oligomerization and the mechanism of the mech-
anochemical coupling are currently unknown. It has been demon-
strated that tyrosine phosphorylation of DynI by c-src induces its
self-assembly and increases its GTPase activity. Isolated DynI
self-assembles in vitro in low-salt buffers into ordered formations of
rings and helical arrays [37], morphologically similar to helical struc-
tures assembled at the necks of budding vesicles [43]. DynI
self-assembly itself is sufﬁcient to stimulate GTPase activity several
fold in the absence of any effector molecule. Noteworthy, we found
that both the DynI GTPase activity and self-assembly were inhibited
by PN. Because DynI self-assembly enhances its GTPase activity,
these ﬁndings also suggest that PN-mediated dephosphorylation
and/or nitration of DynI regulates the GTPase activity by controlling
self-assembly. In addition to the well known mechanisms that regu-
late DynI activities, such as Serine phosphorylation [56] and the inter-
action with the adapter protein Amphiphysin I, a major DynI binding
partner [57], the redox-dependent impairment of DynI properties
suggest an additional regulation mechanism of the endocytotic pro-
cess that may act during neurodegeneration.
One might argue that under neurodegenerative conditions the ni-
tration level is relatively low, resulting in the modiﬁcation of only
0.01%–0.05% of all tyrosine residues [58]. However, nitrated synaptic
proteins may focally accumulate during lifetime, thereby contributing
to a rate-limiting step for the SV cycle. While previously considered a
late-stage epiphenomenon, nitration of tyrosine residues appears tobe an early event that contributes to the onset and progression of sev-
eral neurological diseases [48], as demonstrated for nitrated tau pro-
tein, which co-localizes with markers of early-stage of tauopathies
[59]. In addition, endogenously nitrated proteins, including DynI at
Tyr125, have been identiﬁed in normal mouse brain and many of the
nitrated proteins, localized in pre- and postsynaptic regions of the
neuron, are more extensively nitrated during the progression of
neurodegenerative disorders, suggesting a potential vulnerability of
neurotransmission under oxidative stress and inﬂammation states [60].
In conclusion, our results suggest that post-translational modiﬁca-
tions (phosphorylation and nitration) induced by PN at the nerve termi-
nal play a critical role in modulating mutual afﬁnities and functional
properties of DynI and SYP, both involved in the exo-endocytosis cycle
of SVs.Moreover, theseﬁndings provide a new insight into the regulation
120 C. Mallozzi et al. / Biochimica et Biophysica Acta 1833 (2013) 110–121of DynI function in endocytosis of SVs via control of self-assembly by the
tyrosine residue modiﬁcations.
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